BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1957356)

  • 1. [Mastocytosis].
    Rønnov-Jessen AD; Nielsen PL
    Ugeskr Laeger; 1991 Nov; 153(45):3131-4. PubMed ID: 1957356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic mastocytosis. A review of current diagnostic and therapeutic approaches].
    Pari F; Zamagni MD; Carnevali C; Pagani M; Rabbi C; Cantore M; Cavazzini G; Aitini E; Smerieri F
    Recenti Prog Med; 1999 Mar; 90(3):169-72. PubMed ID: 10228358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology, classification and treatment of human mastocytosis.
    Valent P
    Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mastocytosis: current concepts in diagnosis and treatment.
    Escribano L; Akin C; Castells M; Orfao A; Metcalfe DD
    Ann Hematol; 2002 Dec; 81(12):677-90. PubMed ID: 12483363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphology of mastocytosis].
    Persina IS; Kasimov N
    Arkh Patol; 1987; 49(7):26-32. PubMed ID: 3662856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous mastocytosis in Singapore.
    Tay YK; Giam YC
    Singapore Med J; 1993 Oct; 34(5):425-9. PubMed ID: 8153691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.
    Longley BJ; Tyrrell L; Lu SZ; Ma YS; Langley K; Ding TG; Duffy T; Jacobs P; Tang LH; Modlin I
    Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mastocytosis--a review illustrated by two case reports].
    Dalgaard J; Ritland S; Brinch L; Ikonomou IM
    Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1312-5. PubMed ID: 10868093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric cutaneous mastocytosis: a review of 180 patients.
    Ben-Amitai D; Metzker A; Cohen HA
    Isr Med Assoc J; 2005 May; 7(5):320-2. PubMed ID: 15909466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Most common clinical presentations of cutaneous mastocytosis.
    Bulat V; Mihić LL; Situm M; Buljan M; Blajić I; Pusić J
    Acta Clin Croat; 2009 Mar; 48(1):59-64. PubMed ID: 19623875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis.
    Horny HP; Ruck P; Kröber S; Kaiserling E
    Histol Histopathol; 1997 Oct; 12(4):1081-9. PubMed ID: 9302569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation of reactive and neoplastic human tissue mast cells. An immunohistochemical study using the antibody PC10 (anti-PCNA).
    Horny HP; Schumacher U; McCullagh P; Wehrmann M; Roche WR; Kaiserling E
    J Pathol; 1993 Jul; 170(3):265-70. PubMed ID: 7907655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical varieties of mastocytoses.
    Puretić S; Milavec D
    Acta Med Croatica; 2001; 55(2):61-6. PubMed ID: 11505629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric mastocytosis.
    Kettelhut BV; Metcalfe DD
    J Invest Dermatol; 1991 Mar; 96(3):15S-18S. PubMed ID: 1705949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
    Butterfield JH; Weiler CR
    Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guidelines for the diagnosis, treatment and management of mastocytosis].
    De la Hoz B; González de Olano D; Alvarez I; Sánchez L; Núñez R; Sánchez I; Escribano L
    An Sist Sanit Navar; 2008; 31(1):11-32. PubMed ID: 18496577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual cutaneous findings of urticaria pigmentosa and telangiectasia macularis eruptiva perstans associated with marked myelofibrosis.
    Turchin I; Barankin B; Schloss E
    Int J Dermatol; 2006 Oct; 45(10):1215-7. PubMed ID: 17040445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The liver, spleen, and lymph nodes in mastocytosis.
    Metcalfe DD
    J Invest Dermatol; 1991 Mar; 96(3):45S-46S. PubMed ID: 2002262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basophil/mast cell precursors in mast cell proliferative disorders.
    Denburg JA; Telizyn S; Ahlstedt S; Olafsson JH; Roupe G; Bienenstock J
    Clin Invest Med; 1986; 9(1):21-5. PubMed ID: 3955917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.